GW PHARMACEUTICALS PLC Retained Earnings
GW PHARMACEUTICALS PLC had Retained Earnings of -$915.76 million as of 2021-03-31, per its 10-Q filed 2021-05-03.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2021-05-03
- 2021-03-31: Retained Earnings (Accumulated Deficit) -$915.76M.
- 2020-12-31: Retained Earnings (Accumulated Deficit) -$896.09M.
- 2020-09-30: Retained Earnings (Accumulated Deficit) -$866.94M.
- 2020-06-30: Retained Earnings (Accumulated Deficit) -$854.75M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2021-03-31 | -$915.76M 10-Q · filed 2021-05-03 |
| 2020-12-31 | -$896.09M 10-Q · filed 2021-05-03 |
| 2020-09-30 | -$866.94M 10-Q · filed 2020-11-05 |
| 2020-06-30 | -$854.75M 10-Q · filed 2020-08-07 |
| 2020-03-31 | -$845.92M 10-Q · filed 2020-05-11 |
| 2019-12-31 | -$837.96M 10-K · filed 2021-02-26 |
| 2019-09-30 | -$813.01M 10-Q · filed 2019-11-06 |
| 2019-06-30 | -$799.26M 10-Q · filed 2019-08-07 |
| 2019-03-31 | -$879.00M 10-Q · filed 2019-05-08 |
| 2018-12-31 | -$828.94M 10-K · filed 2020-02-27 |
| 2018-09-30 | -$757.03M 10-KT · filed 2019-02-28 |
| 2017-09-30 | -$461.87M 10-KT · filed 2019-02-28 |